T he human disorder familial combined hyperlipidemia is associated with premature atherosclerotic heart disease 1 -3 ; it is the most common form of familial hyperlipidemia in survivors of myocardial infarction. 12 Affected patients exhibit elevated plasma levels of very low density lipoprotein I and "'1 (using LDL) "Sink" assumption (using LDL) Labeling of arterial lipoproteins (using LDL, IDL, and VLDL) 37 °C incubation (using LDL) of rabbits For methodology, see "Protocol for Influx Experiments" and "Validation of Conditions for Influx Experiments" in the "Methods" section. Several of the rabbits were also studied for other purposes, which will be reported elsewhere.
LDL, low density lipoprotein; IDL, intermediate density lipoprotein; VLDL, very low density lipoprotein; Sf, flotation rate in Svedberg units.
imal model, therefore, offers the opportunity to study the relative atherogenicity of VLDL, IDL, and LDL under conditions where plasma levels of these lipoprotein fractions are elevated.
We have made the assumption that the atherogenic potential of an apo B-containing lipoprotein reflects the rate at which it may deliver cholesterol into the arterial intima; on this basis we have compared the arterial influx in vivo of VLDL, IDL, and LDL in this rabbit strain. Furthermore, we have attempted to delineate some determinants of influx.
Methods

Animals
The 49 rabbits (Table 1) , 32 females and 17 males, weighing 3.3-5.6 kg and aged 9-35 months, were descendants of the founder male of the St. Thomas's Hospital rabbit strain 9 ; the parents of the rabbits were either two hyperlipidemic rabbits or one hyperlipidemic and one normolipidemic rabbit, the latter also being a New Zealand White rabbit. SG 1 pellets (Grain Harvesters Ltd., Wigham, UK) were fed to the rabbits ad libitum. Plasma cholesterol and triglyceride levels in the 49 rabbits ranged from 1.2 to 23.1 mmol/1 and from 0.5 to 9.1 mmol/1, respectively. Experimental protocols were in accordance with the UK Home Office guidelines for experiments with animals.
Preparation of Labeled Lipoproteins
VLDL, IDL, LDL, and Sf 12-60 lipoprotein (where Sf is the rate of flotation in Svedberg units) were prepared from freshly drawn, nonfasting rabbit blood containing the anticoagulant Na 2 EDTA (1.2 mg/ml, Sigma Chemical Co., Poole, UK); the antibiotics chloramphenicol (80 ^.g/ml; Sigma) and gentamicin sulfate (80 /Ag/ml; Sigma); and the protease inhibitors e-amino-n-caproic acid (2.6 mg/ml; Sigma), benzamidine (10 Atg/ml; Sigma), and aprotinin (5-9 kallikrein units/ml; Sigma). Lipoproteins were separated promptly at 4°C from an average of 12 ml plasma with salt solutions and with the previously mentioned concentrations of the two antibiotics, the three protease inhibitors, and 0.1 mg/ml Na 2 EDTA. VLDL (d< 1.006 g/ml), IDL (1.006 g/ml<d<1.019 g/ml), and LDL (1.019 g/ml <rf< 1.063 g/ml) were isolated as the top fractions after sequential ultracentrifugation in a Kontron TFT 45.6 rotor (Watford, Hertfordshire, UK), for 2.4xlO 6 , 2.6xlO 6 , and 2.9xl0 6 g tv • hour (where av=average) in solvent densities of 1.006, 1.019, and 1.063 g/ml, respectively. To isolate Sf 12-60 lipoprotein, Sf>60 lipoprotein was first isolated and discarded; in each tube, 3 ml plasma was overlayered with 2 ml of d=1.006 g/ml salt solution in 13x64-mm polyallomer tubes (Kontron) and ultracentrifuged for I.lxlO 7^-minute 11 in a Kontron TFT 45.6 rotor; the top 1.5 ml was the Sf>60 lipoprotein. Subsequently, Sf 12-60 lipoprotein was isolated as the top fraction after ultracentrifugation at d=1.019 g/ml. Lipoprotein fractions were washed by a further ultracentrifugation step at their upper density limits to minimize contamination.
Before iodination, lipoproteins were equilibrated with saline containing antibiotics, protease inhibitors, and Na 2 EDTA as described ("saline") with the use of PD-10 gel filtration columns (Sephadex G-25M, Pharmacia, Uppsala, Sweden). Iodination was performed according to the modification by Bilheimer et al 12 of McFarlane's iodine monochloride method 13 as follows. In 0.4-1.8 ml saline containing lipoproteins, pH was adjusted to 10 with 0.3-0.5 ml glycine buffer To reduce the amount of exchangeable iodine label, that is, label not attached to apo B in influx studies with labeled VLDL, IDL, or Sf 12-60 lipoprotein, each of these lipoprotein fractions as well as labeled LDL was incubated with a rabbit plasma fraction containing unlabeled high density lipoprotein (HDL) and plasma lipid transfer protein (d> 1.063 g/ml) for 48 hours at 37°C. Subsequently, lipoprotein fractions were reisolated by ultracentrifugation at their upper density limits and finally dialyzed against saline overnight at 4°C. The 48-hour incubation increased the percentage of label attached to apo B, that is, isopropanol-precipitable counts, from 36±10% to 62±8% (four samples) for labeled VLDL, from 76 ±2% to 91 ±2% (five samples) for labeled IDL, and from 64±3% to 82±2% (eight samples) for labeled LDL. Labeled lipoprotein preparations were used for influx or validation experiments immediately after preparation, that is, not more than 7 days after donor blood was drawn and not more than 4 days after iodination, and were filtered through 0.22-jim filters (Millipore S.A., Molsheim, France) just before injection.
Protocol for Influx Experiments
Because plasma concentrations of IDL and VLDL after an overnight fast may not represent the average lipoprotein levels to which the arterial wall is exposed, influx experiments were performed with nonfasted animals that were fed ordinary chow ad libitum. Of the 40 rabbits used for influx experiments (rabbits 1, 6, 7, and 13-49; Table 1 ), 23 were injected with labeled autologous lipoproteins, and the remaining 17 were injected with labeled lipoproteins similar to their own lipoproteins; all labeled lipoproteins were from rabbits of the St. Thomas's Hospital strain. The labeled preparations (5.2±0.5 ml, n=40) containing either two labeled lipoprotein fractions (rabbits [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] or only one fraction (rabbits 1, 6, 7, 13, and 26-49) labeled with 125 I (177±23 /xCi, n=30) and/or 131 I (34±4 fid, n=22) were injected intravenously. Volumes of distribution of these injected doses were 30.2±1.0 ml/kg and 30.6±1.0 ml/kg for 125 I-and 131 I-labeled lipoproteins, respectively; the volume of distribution was calculated as the injected dose (counts per minute) divided by radioactivity concentration in plasma (counts per minute per millimeter) 10 minutes after injection and divided by the weight of the rabbit (kilograms). Because these volumes of distribution are not larger than plasma volumes of cholesterol-fed rabbits as determined with albumin labeled in vivo, 16 it is unlikely that even 1-2% of the dose was denatured; such a damaged dose would be removed rapidly by the liver, and the volume of distribution would then have been larger than plasma volume.
Nonfasting blood samples containing antibiotics, protease inhibitors, and Na 2 EDTA as described were drawn from ear veins at timed intervals after injection of the dose, and the rabbits were killed 3.3±0.1 hours («=40) later by intravenous injection of pentobarbitone sodium (50-100 mg/kg; May & Baker Ltd., Dagenham, UK). The thorax was opened, and the rabbit was perfused with 1 1 saline introduced into the left ventricle of the heart after the inferior vena cava was severed. Subsequently, the aorta was excised, the adventitia was removed, and the vessel was opened longitudinally and rinsed with saline. The aorta was fixed with pins on a corkboard, and the area was outlined on graph paper; the vessel was divided into the aortic arch (from the heart to the first intercostal arteries), the thoracic aorta (to the diaphragm), and the abdominal aorta (to the bifurcation). The area of the arch, thoracic aorta, and abdominal aorta was 6.2±0.1 cm 2 , 7.7±0.1 cm 2 , and 7.7±0.1 cm 2 («=49), respectively. As a measure of the extent of atherosclerosis, the fraction of the total aortic intimal surface in each of these aortic regions that showed lesions was graded visually as 0%, 2%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, or 100%. The aortas were all graded by the same person (B.G.N.) without knowledge of the rabbits' lipoprotein levels or kinetic characteristics. To validate grading of aortic lesions, the arches, thoracic aortas, and abdominal aortas from another set of rabbits from the St. Thomas's Hospital strain The intima-inner media was stripped from the remaining media in each of the three aortic regions, minced with scissors, and placed in a shaker with 1.5 ml saline for 3 days at 4°C to extract lipoproteins (see "Validation" section). This suspension then underwent isopropanol precipitation (see below).
The VLDL, IDL, LDL, and HDL (d> 1.063 g/ml) were isolated from plasma samples by sequential ultracentrifugation. In experiments with Sf 12-60 lipoprotein (rabbits [23] [24] [25] 
Analyses
Apo B was precipitated with isopropanol 18 in aliquots of the doses, in minced and saline-treated arterial extracts, and in aliquots of lipoprotein fractions from plasma samples; human apo B-containing lipoproteins (d< 1.063 g/ml) were added to all samples as carriers before precipitation. A 1-or 1.5-ml sample was combined with 1 or 1.5 ml 100% isopropanol (BDH Ltd., Poole, UK) in a 15x56-mm plastic counting vial (Sterilin Ltd., Feltham, UK). After 1 minute of vigorous mixing, the samples were incubated for 3 days at 4°C and then centrifuged at l,50Qg for 30 minutes at 4°C. The supernatant was removed, and the precipitate (for arterial tissue, this included the minced tissue) was washed twice with 2 ml 50% isopropanol and finally with 2 ml 100% isopropanol to ensure complete lipid extraction. 18 To obtain equal counting conditions, 2 ml 50% isopropanol was added to the precipitate before it and the various washes were counted in an LKB-Wallac 1280 Ultrogamma double-channel gamma counter (Pharmacia-LKB Biotechnology, Milton Keynes, UK). Part of the radioactivity in the washes was assumed to be due to free iodine; hence, trichloroacetic acid (TCA) precipitation was performed on other aliquots on the same day as the isopropanol precipitation, and the isopropanol-precipitable counts were corrected accordingly; the counts in the TCA supernatant (free iodine counts) were subtracted from the counts in the isopropanol washes before calculation of the percent of label precipitable with isopropanol, as shown in Table 2 . For arterial tissue, where all tissue was used for isopropanol precipitation, the medial tissue was used to estimate TCA-precipitable counts. On the same day, aliquots of the dose and of plasma lipoproteins, all with added carrier plasma, were also extracted and precipitated with chloroform/methanol (1:1, vol/vol) to estimate extractable lipid counts. As with isopropanol precipitation, extractable lipid counts were corrected for counts due to free iodine, which were estimated as counts in the supernatant after TCA precipitation.
Validation of Conditions for Influx Experiments
To estimate the contribution of adhering plasma to radioactivity in arterial intima-inner media, I25 Iand/or 131 I-labeled lipoproteins were injected intravenously into rabbits 1-5 (Table 1) 10-13 minutes before removal of arterial tissue, as described above. Radioactivity present in the intima-inner media was assumed to represent surface contamination. Contamination was similar whether labeled LDL (one sample), IDL (three samples), or labeled VLDL (two samples) was used, and it was similar in the intima with and without lesions. The average contamination values for the arch, thoracic aorta, and abdominal aorta were 13.7±3.6 nl/cm 2 (six samples), 7.6±2.5 nl/cm 2 , and 8.8 ±2.0 nl/cm 2 . These mean values are similar to values obtained previously in three cholesterol-fed rabbits that had been injected with iodinated LDL. 19 Influx and intimal clearance were, in the present study of all rabbits, calculated based on uncorrected radioactivity values for intima-inner media as well as on radioactivity in the intima-inner media corrected for contamination. After correction for plasma contamination, radioactivity in the intimainner media of the 40 rabbits used for influx studies was 81 ±2% (156 samples) of the uncorrected values. Contamination-corrected values are reported in the present article; our conclusions were similar whether uncorrected or plasma contamination-corrected values were considered.
In the present study, it is necessarily assumed that lipoproteins, iodinated with either I-labeled lipoproteins for arterial influx measurements has previously been observed in cholesterol-fed rabbits. 20 Arteries were exposed to circulating labeled lipoproteins for an average of only 3.3 hours, with the intention that transfer of labeled lipoproteins from the arterial intima during the exposure period would be small compared with arterial influx; that is, that the arterial intima would behave as a "sink." To validate this, 125 I-labeled LDL and 131 I-labeled LDL were injected intravenously into rabbit 7 at two different time points before removal of the aorta (Figure 1 ). Arterial influx of LDL cholesterol increased almost linearly with time for 5 hours, which suggests that for such a short influx period, the sink assumption is appropriate. If efflux of labeled LDL had been significant compared with influx of labeled LDL during the 5 hours, then the three curves in Figure 1 would have been curvilinear with a concavity toward the x axis. Results similar to those in Figure 1 have previously been reported for two cholesterolfed rabbits and iodinated LDL. 19 After intravenous injection of iodinated LDL, IDL, and/or VLDL into rabbits 8-12, the aorta was excised an average 3.6 hours later, minced, and saline (d=1.006 g/ml)-extracted as described. After centrifugation at l,000g for 10 minutes at 4°C, the supernatant was removed and the minced tissue washed twice with saline. The combined washes with added carrier plasma were ultracentrifuged to isolate arterial VLDL, IDL, and LDL. These fractions were precipitated with isopropanol, and the counts in the precipitated apo B were determined.
To test if the incubation of the labeled lipoproteins at 37°C for 48 hours with HDL and plasma lipid transfer protein did affect arterial influx or intimal clearance of such lipoproteins, one aliquot of LDL was iodinated with I and incubated as described. Another aliquot of the same LDL kept at 4°C was iodinated with 131 I 3 days later, when the 125 I-labeled LDL had been reisolated. The two aliquots were mixed, dialyzed overnight against saline, and then injected intravenously into rabbit 13. Arterial influx of the 37°C-incubated LDL was 89%, 93%, and 91% of that of nonincubated LDL in the arch, thoracic aorta, and abdominal aorta, respectively. Considering the large variation usually found in arterial influx measurements, the two sets of influxes are similar. Furthermore, the plasma decay curves for the incubated and nonincubated LDL never differed by more than 1%.
Calculations
Calculations of arterial intimal clearance and influx of lipoproteins were based on radioactivity in apo B in plasma lipoproteins and in the total arterial intimainner media after correction for contamination; in 10 rabbits used for measurements of LDL influx only, influx calculations were based on total counts in plasma and in arterial intima-inner media (corrected for contamination) as previously performed. Arterial intimal clearance of lipoproteins (nanoliters per square centimeter per hour) was calculated by the sink method; radioactivity in the intima-inner media (counts per minute per square centimeter) was divided by the time-averaged radioactivity of all plasma lipoprotein fractions combined during the average 3.3-hour influx period (counts per minute per nanoliter) and by the length of the influx period (hours). Arterial influx of lipoprotein cholesterol (picomoles per square centimeter per hour) was calculated as intimal clearance (nanoliters per square centimeter per hour) multiplied by the plasma concentration of the appropriate lipoprotein cholesterol (picomoles per nanoliter). The calculation of lipoprotein cholesterol influx assumes that the intimal clearance measured for apo B is also valid for the cholesterol moiety of the lipoproteins. Stender and Zilversmit 21 have provided evidence that in cholesterol-fed rabbits, cholesteryl ester and protein of LDL enter the arterial intima-inner media in the same proportions as are present in plasma LDL.
Statistics
Values are presented as mean±SEM. Univariate and multiple linear-regression analyses were performed with the MINITAB program. 22 The Wilcoxon matchedpairs signed-rank test was performed manually.
Electron Microscopy of Negatively Stained Lipoproteins
The average diameters of LDL, IDL, and VLDL particles from two rabbits of the St. Thomas's Hospital strain were determined from electron photomicrographs of negatively stained lipoproteins. 23 In brief, lipoprotein fractions were dialyzed against a volatile buffer consisting of 125 mmol/1 ammonium acetate, 2.6 mmol/1 ammonium carbonate, and 0.26 mmol/1 Na 2 EDTA (pH 7.4) and then mixed with the negative stain phosphotungstate just before examination and photography in a transmission electron microscope at a magnification of x 29,000 on the negative. The diameters of 100 randomly selected lipoprotein particles were determined from prints at a total magnification of x 200,000. To avoid inclusion of artificially large VLDL diameters due to flattening of lipoprotein particles, two different approaches were used. 23 Some aliquots of VLDL were fixed with a 2% solution of OsO 4 in 150 mmol/1 sodium cacodylate buffer (pH 7.4) before negative staining, whereas other aliquots were kept at 37°C during the entire negative staining procedure.
Results
Labeled Lipoproteins in Plasma and Arterial Intima
The major part of the iodine label was attached to the apo B of LDL, IDL, and VLDL, whether measured in the dose, in plasma lipoproteins, or in the intima-media of the aortic arch ( Table 2 ). The present article is concerned only with the label in apo B in plasma and intima-media.
When labeled LDL was injected intravenously, >95% of the apo B label in plasma remained in the LDL fraction throughout the influx period (Table 3) . However, when labeled IDL was injected, about 25% of the apo B label appeared in plasma LDL. Similarly, after intravenous injection of labeled VLDL, about 10% of the apo B label appeared in plasma IDL, and after injection of labeled Sf 12-60 lipoprotein, about 10% of the apo B label appeared in apo B of LDL.
In experiments with labeled LDL, about 95% of the apo B label in arterial VLDL, IDL, and LDL Values are percent and are mean±SEM, based on the number of tissues shown in parentheses. The VLDL fraction was assayed in two segments of aorta (arch and combined thoracic and abdominal aortas) from one rabbit, labeled IDL was assayed in the same two segments of aorta in three different rabbits, and labeled LDL was assayed in two aortic segments in one rabbit and in the whole aorta combined in two other rabbits. Some rabbits had two different labeled lipoprotein fractions injected simultaneously. After a 3-4-hour exposure to intravenously injected labeled lipoproteins, arterial intima-inner media samples were minced with a pair of scissors and then extracted in saline at 4°C for 24-72 hours. Subsequently, lipoproteins were separated in the saline extracts by ultracentrifugation and finally, the lipoprotein fractions were subjected to apolipoprotein B precipitation with isopropanol.
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FIGURE 2. Plots of influx of low density Upoprotein (LDL) cholesterol into various aortic intima-inner media in 25 rabbits, as a function of the extent of aortic lesions and of plasma LDL cholesterol. Influx was calculated as radioactivity in tissue (counts per minute per square centimeter), corrected for contamination, divided by the time-averaged radioactivity concentration in plasma (counts per minute per nanoliter) and by the length of the influx period (hours), and then multiplied by plasma LDL cholesterol (picomoles per nanoliter). Note that the y axis (influx) of thoracic and abdominal aortas is half that of the aortic arch.
was in the LDL fraction (Table 4 ). In IDL experiments, about half of the extractable arterial apo B label was in IDL and about half in LDL, and when labeled VLDL was injected, approximately equal amounts of extractable apo B label were found in arterial VLDL, IDL, and LDL. Of the total radioactivity in arterial intima-inner media, on average, only 43%, 38%, and 19% in LDL, IDL, and VLDL experiments, respectively, were in the isolated arterial VLDL, IDL, and LDL combined (data not shown). The remaining label was not extracted into these fractions (see first paragraph of discussion).
Arterial Influx of Low Density Lipoprotein, Intermediate Density Lipoprotein, and Very Low Density Lipoprotein Cholesterol
Previously, it has been difficult to demonstrate that arterial influx of lipoproteins is dependent on their plasma concentration. One possible reason is a large interindividual variation in influx (despite similar plasma concentrations), probably caused by differences in the extent and stage of arterial lesions. In the present article, these potential determinants have been separately assessed as shown in Figures 2-4 , so that arterial influx can be independently assessed as a function of lipoprotein cholesterol concentration in plasma and as a function of the extent of lesions in the arterial intima.
Arterial influx of LDL cholesterol increased linearly with increasing extent of lesions in the arterial intima and with increasing plasma concentration of LDL cholesterol, as separately assessed in the arch, thoracic aorta, and abdominal aorta (Table 5) . Similarly, arterial influx of IDL cholesterol increased linearly with increasing extent of arterial lesions and also with increasing plasma IDL cholesterol (Table  5 ). Arterial influx of VLDL cholesterol also increased linearly, both with the extent of arterial lesions and with increasing VLDL cholesterol in plasma (Table 5 ). Plasma LDL cholesterol and plasma IDL cholesterol were both positively and linearly correlated with percentage of the intima with lesions at all three aortic sites (p<0.05), but for plasma VLDL cholesterol, this was only true for the aortic arch (data not shown).
By using multiple linear regression of lipoprotein cholesterol and the percent area showing lesions simultaneously as predictors of influx, the independent effect of each predictor was evaluated (Table 6) . Concentrations of LDL cholesterol in plasma and percent lesions in the intima were each positively and linearly associated with arterial influx of LDL cholesterol, although for plasma LDL cholesterol, this was significant at the 0.05 level only for the aortic arch. When the arterial influx of LDL cholesterol value was square-root transformed, a better fit was obtained for the multiple linear regression (R 2 increased from 0.65, 0.64, and 0.73 to 0.82, 0.81, and 0.84 for the arch, thoracic aorta, and abdominal aorta, respectively); LDL cholesterol concentration was then positively associated with arterial influx at all three aortic sites. Plasma IDL cholesterol was independently linearly positively associated with influx of IDL cholesterol in two of three aortic sites, but in these IDL experiments, the percentage of arterial surface showing lesions only reached a statistically significant, independent linear association with influx at one aortic site. Plasma VLDL choles- 
FIGURE 3. Plots of influx of intermediate density lipoprotein (IDL) cholesterol into various aortic intima-inner media in 14 rabbits, as a function of the extent of aortic lesions and of plasma IDL cholesterol. Note that the y axis (influx) of thoracic and abdominal aortas is half that of the aortic arch.
terol was independently linearly positively associated with influx at all three aortic sites, and similarly, lesion percentage was linearly positively associated with influx in two of the three tissues. The univariate and multiple linear regressions in Tables 5 and 6 24 
FIGURE 4. Plots of influx of very low density lipoprotein (VLDL) cholesterol into various aortic intima-inner media in 10 rabbits, as a function of the extent of aortic lesions and of plasma VLDL cholesterol. Note that the y axis (influx) of thoracic and abdominal aortas b half that of the aortic arch.
Discussion
The aim of the present study was to identify determinants of the rate of transfer of cholesterol from plasma LDL, IDL, and VLDL into the arterial intima. For this purpose, we employed genetically hyperlipidemic rabbits of the St. Thomas's Hospital strain. Because >95% of the apo B label remained in the LDL fraction in plasma in LDL experiments and because about 95% of the apo B label of saline extracts from intima was in the LDL fraction, influx in these experiments represents influx of LDL particles. However, when labeled IDL and VLDL were injected, about 25% and 10% of the apo B label appeared in plasma LDL and IDL during the time course of the experiments, respectively, and therefore, some of the influx in these IDL and VLDL experiments may have been due, in part, to arterial influx of IDL-derived and VLDL-derived lipoproteins. This is supported by the data in and of VLDL-derived IDL and LDL cannot be determined from these data because, on average, only 38% and 19% of the total intimal radioactivity was recovered in the apo B-containing lipoproteins isolated from the arterial samples in these validation experiments. It is likely that the remaining label is due to apo B-containing lipoproteins that are partly degraded or attached to arterial components; whether these lipoproteins entered the intima as VLDL, IDL, or LDL particles was not determined. Because influx and intimal clearance calculations were based on total arterial apo B radioactivity, the poor recovery in these validation experiments does not affect the conclusions of the present article. The results in Table 4 , as well as previous results of human studies from this laboratory, 25 demonstrate that plasma IDL and VLDL at least partly enter the arterial wall as IDL and VLDL particles. Accordingly, in the present study, influx of VLDL cholesterol is assumed to comprise influx of cholesterol in VLDL and VLDL-derived particles, and influx of IDL cholesterol is assumed to include influx of cholesterol in IDL and IDL-derived particles.
Plasma Concentration of Lipoproteins as a Determinant of Arterial Influx
The present studies suggest that arterial influx of LDL, IDL, and VLDL cholesterol in genetically hyperlipidemic rabbits is linearly and positively related to the plasma concentration of the three lipoproteins, independent of the extent of arterial lesions. However, because the square-root-transformed and the logarithmically transformed lipoprotein cholesterol influx val-ues were, to some extent, also associated with lipoprotein concentration in plasma and extent of aortic lesions, our data do not conclusively demonstrate a linear relation between lipoprotein concentration in plasma and lipoprotein influx into the arterial intima. Niehaus et al 26 demonstrated a univariate, positive association between plasma LDL cholesterol and arterial influx of LDL apo B in humans, but it could not be excluded that this association reflected a simultaneous association between plasma LDL levels and the extent of arterial lesion. Also in support of our finding, Newman and Zilversmit 27 demonstrated that a group of cholesterol-fed rabbits with fivefold higher plasma cholesterol levels than a group of "normocholesterolemic" rabbits had three times the arterial influx of free and esterified cholesterol compared with the normocholesterolemic rabbits; this was not a function of the extent of arterial lesion.
The linear relation between arterial influx of cholesterol in LDL, IDL, VLDL, and their product lipoproteins and plasma concentrations of LDL cholesterol in the range 0.2-6.4 mmol/1, IDL cholesterol in the range 0.1-7.0 mmol/1, and VLDL cholesterol in the range 0.7-8.5 mmol/1, respectively, suggest that nonspecific molecular sieving may be a quantitatively important mechanism for transfer of these lipoproteins into the arterial intima across endothelial cells. In keeping with this, arterial influx of LDL in normal rabbits does not depend on endothelial LDL receptors, 28 and in cholesterol-fed rabbits, 2021 humans, 29 and pigs, 30 arterial influx of lipoproteins depends on lipoprotein particle size. However, from our data it cannot be ruled out that saturation kinetics for arterial influx of lipoproteins might occur at plasma concentrations of LDL, IDL, and VLDL above those examined in the present study.
Because the amount of cholesterol per VLDLderived IDL particle is less than that per VLDL particle, arterial influx of VLDL cholesterol may have been slightly overestimated. A similar slight overestimation of IDL cholesterol influx, but not of LDL cholesterol influx, may have occurred. However, because it is likely that a comparable percentage of overestimation would occur in rabbits with high and low arterial influx, the relation between plasma concentration and influx, as well as the relation between lesion size and influx, would not be affected by such an overestimation.
Extent of Arterial Lesion as a Determinant of Arterial Influx
That the extent/severity of atherosclerosis is a determinant of influx of lipoproteins is in accordance with previous studies of cholesterol-fed rabbits, 161931 -34 monkeys, 35 and humans. 25 - 36 However, the present demonstration that arterial influx of LDL, IDL, and VLDL cholesterol may be linearly dependent on the extent of arterial lesion, independent of the plasma lipoprotein concentration, has not previously been demonstrated. Schwenke and Carew 37 have reported that in cholesterol-fed rabbits, intra-arterial concentration of LDL increases before development of fatty streak lesions, implying that the extent of arterial lesions may be determined, at least partly, by the extent of LDL influx.
Lipoprotein Size as a Determinant of Arterial Influx
Stender and Zilversmit 21 demonstrated, in cholesterol-fed rabbits, an inverse relation between the particle diameters of albumin, HDL, LDL, and £-VLDL macromolecules and their arterial intimal clearance when such intimal clearances were measured within the same aortas. Thus, influx was assessed after normalization for differences in plasma concentrations of lipoproteins and for extent of arterial lesion. A similar relation between particle size and intimal clearance of HDL and LDL has been demonstrated in humans 29 and pigs. 30 In the previous studies cited, labeled free and esterified cholesterol was employed; our investigation, employing iodinated lipoproteins, has confirmed that such an inverse relation exists and excludes the notion that the previous demonstrations were influenced by the mathematical methods employed. 38 The relation is true even for LDL, IDL, and VLDL, for which the differences in average diameter are only about 30%; in the earlier studies cited, the differences in diameter between the lipoprotein fractions examined were twofold to threefold. The much smaller diameter difference between the lipoproteins examined in the present study may explain the less-pronounced size dependency demonstrated in Figure 5 than that reported in the previous articles. The diameter of LDL has also been shown to be a determinant of LDL intimal clearance. 20 
Comparison of the Atherogenic Potential of Very Low Density Lipoprotein, Intermediate Density Lipoprotein, and Low Density Lipoprotein
To the extent that the ability of an apo B-containing lipoprotein fraction to deliver cholesterol from plasma into the arterial intima is a measure of its atherogenic potential, our findings suggest that, at least in rabbits of the St. Thomas's Hospital strain, IDL and VLDL may share with LDL the potential for promoting atherogenesis. This is supported by our recent article 39 showing that IDL cholesterol and Sf 12-60 lipoprotein cholesterol were better predictors of the extent of aortic atherosclerosis in the St. Thomas's Hospital rabbit strain than was LDL cholesterol. Although the intimal clearance of IDL and VLDL was 15-35% less than that of LDL, the cholesterol influx from the IDL and VLDL fractions may well have exceeded that from the LDL fraction in many rabbits; the cholesterol content in IDL plus VLDL was greater than that in LDL in many animals (data not shown).
In humans without major genetic forms of hyperlipidemia, there is evidence that LDL as well as IDL 5 " 8 may contribute to the atherogenic process. Furthermore, accelerated atherosclerosis in humans is a feature of 1) type III hyperlipidemia, in which Sf 12-60 lipoprotein levels (IDL plus small VLDL) are grossly elevated while LDL levels typically are low 40 ; 2) chronic renal failure and non-insulin-dependent diabetes mellitus, in each of which lipoprotein abnormalities include elevated levels of Sf 12-60 lipoprotein 4142 ; and 3) familial combined hyperlipidemia, in which IDL and VLDL, and/or LDL levels may be elevated.
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When plasma triglyceride is only moderately elevated (2-10 mmol/1) as in rabbits of the St. Thomas's Hospital strain, in cholesterol-fed rabbits, and in the clinical disorders discussed above, particles within the VLDL-IDL classes may well be atherogenic, as such relatively small particles appear to have access to the arterial intima. In contrast, when plasma triglyceride is severely elevated, as in humans with lipoprotein lipase deficiency or apolipoprotein C-II deficiency or in alloxan-diabetic, cholesterol-fed rabbits, most lipoproteins in the VLDL fraction (d< 1.006 g/ml) are large (>75 nm in diameter; Sf>400 lipoprotein), 1643 and these large lipoproteins have been shown to be excluded from entering the arterial intima in diabetic, cholesterol-fed rabbits. 19 Humans with lipoprotein lipase or apolipoprotein C-II deficiency, like diabetic, cholesterol-fed rabbits, appear to be relatively protected from atherosclerosis. 43 -44 In conclusion, our present results in genetically hyperlipidemic rabbits are compatible with a linear dependency of arterial influx of LDL-, IDL-, and VLDL-derived cholesterol on plasma concentrations of these three lipoproteins; arterial influx of lipoproteins may, therefore, involve nonspecific molecular sieving. Furthermore, to the extent that the intimal influx of apo B-containing lipoproteins is a determinant of atherogenicity, the data suggest that when plasma levels of smaller VLDL and IDL are elevated, these lipoproteins share with LDL the potential for promoting atherosclerosis.
